# An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis

> **NCT01920893** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 60 (actual)

## Conditions studied

- Nasal Polyps

## Interventions

- **DRUG:** Placebo (for dupilumab)
- **DRUG:** Dupilumab
- **DRUG:** Mometasone furoate nasal spray

## Key facts

- **NCT ID:** NCT01920893
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920893, "An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01920893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*